We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Santhera Announces First Patient Dosing with Omigapil in CMD

News   Jul 21, 2015

 
Santhera Announces First Patient Dosing with Omigapil in CMD
 
 
Advertisement
 

RELATED ARTICLES

Nanoparticle-Infused Contact Lenses Correct Color Blindness

News

Dyed contact lenses currently in development for color blindness are potentially harmful and unstable. Now, researchers have infused contact lenses with gold nanoparticles to create a safer way to see colors.

READ MORE

Drug Shown To Help Diabetes Patients Lose Weight in Clinical Study

News

In a multicenter Phase 3 clinical study, the drug semaglutide was shown to help patients with diabetes lose on average 10 to 17% of their body weight.

READ MORE

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE